Thromboxane A₂ receptor signaling facilitates tumor colonization through P-selectin-mediated interaction of tumor cells with platelets and endothelial cells. 2012

Yoshio Matsui, and Hideki Amano, and Yoshiya Ito, and Koji Eshima, and Tastunori Suzuki, and Fumihiro Ogawa, and Akira Iyoda, and Yukitoshi Satoh, and Shintaro Kato, and Masaki Nakamura, and Hidero Kitasato, and Shuh Narumiya, and Masataka Majima
Department of Thoracic Surgery, Kitasato University School of Medicine, Kanagawa, Japan.

Thromboxane A(2) (TXA(2) ) is a prostanoid formed by thromboxane synthase using the cyclooxygenase product, prostaglandin H(2), as the substrate. TXA(2) was shown to enhance tumor metastasis, but the underlying mechanism remains unclear. B16F1 melanoma cells were intravenously injected into TXA(2) receptor (TP) knockout mice (TP(-/-) ) and wild-type littermates (WT). TP(-/-) showed a reduction in B16F1 lung colonization and mortality rate, which were associated with a decreased number of platelets. Platelet activation as assessed by P-selectin expression was suppressed in TP(-/-) . A selective P-selectin neutralizing antibody decreased the lung colonization in WT mice, but not in TP(-/-) . The expression of P-selectin glycoprotein ligand-1 in B16F1 and HUVEC were enhanced by treatment with U46619, a thromboxane analog. The plasma levels of vascular endothelial growth factor (VEGF) and stromal-derived factor (SDF)-1 were lower in TP(-/-) . In TP(-/-) , the mobilization of progenitor cells expressing CXCR4(+) VEGFR1(+) from bone marrow and the recruitment of those cells to lung tissues were suppressed. These results suggest that TP signaling plays a critical role in tumor colonization through P-selectin-mediated interactions between platelets-tumor cells and tumor cells-endothelial cells through the TP signaling-dependent production of VEGF and SDF-1, which might be involved in the mobilization of VEGFR1(+) CXCR4(+) cells. Blockade of TP signaling might be useful in the treatment of tumor metastasis.

UI MeSH Term Description Entries
D008546 Melanoma, Experimental Experimentally induced tumor that produces MELANIN in animals to provide a model for studying human MELANOMA. B16 Melanoma,Melanoma, B16,Melanoma, Cloudman S91,Melanoma, Harding-Passey,Experimental Melanoma,Experimental Melanomas,Harding Passey Melanoma,Melanomas, Experimental,B16 Melanomas,Cloudman S91 Melanoma,Harding-Passey Melanoma,Melanoma, Harding Passey,Melanomas, B16,S91 Melanoma, Cloudman
D008562 Membrane Glycoproteins Glycoproteins found on the membrane or surface of cells. Cell Surface Glycoproteins,Surface Glycoproteins,Cell Surface Glycoprotein,Membrane Glycoprotein,Surface Glycoprotein,Glycoprotein, Cell Surface,Glycoprotein, Membrane,Glycoprotein, Surface,Glycoproteins, Cell Surface,Glycoproteins, Membrane,Glycoproteins, Surface,Surface Glycoprotein, Cell,Surface Glycoproteins, Cell
D008810 Mice, Inbred C57BL One of the first INBRED MOUSE STRAINS to be sequenced. This strain is commonly used as genetic background for transgenic mouse models. Refractory to many tumors, this strain is also preferred model for studying role of genetic variations in development of diseases. Mice, C57BL,Mouse, C57BL,Mouse, Inbred C57BL,C57BL Mice,C57BL Mice, Inbred,C57BL Mouse,C57BL Mouse, Inbred,Inbred C57BL Mice,Inbred C57BL Mouse
D009362 Neoplasm Metastasis The transfer of a neoplasm from one organ or part of the body to another remote from the primary site. Metastase,Metastasis,Metastases, Neoplasm,Metastasis, Neoplasm,Neoplasm Metastases,Metastases
D009369 Neoplasms New abnormal growth of tissue. Malignant neoplasms show a greater degree of anaplasia and have the properties of invasion and metastasis, compared to benign neoplasms. Benign Neoplasm,Cancer,Malignant Neoplasm,Tumor,Tumors,Benign Neoplasms,Malignancy,Malignant Neoplasms,Neoplasia,Neoplasm,Neoplasms, Benign,Cancers,Malignancies,Neoplasias,Neoplasm, Benign,Neoplasm, Malignant,Neoplasms, Malignant
D001792 Blood Platelets Non-nucleated disk-shaped cells formed in the megakaryocyte and found in the blood of all mammals. They are mainly involved in blood coagulation. Platelets,Thrombocytes,Blood Platelet,Platelet,Platelet, Blood,Platelets, Blood,Thrombocyte
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D015398 Signal Transduction The intracellular transfer of information (biological activation/inhibition) through a signal pathway. In each signal transduction system, an activation/inhibition signal from a biologically active molecule (hormone, neurotransmitter) is mediated via the coupling of a receptor/enzyme to a second messenger system or to an ion channel. Signal transduction plays an important role in activating cellular functions, cell differentiation, and cell proliferation. Examples of signal transduction systems are the GAMMA-AMINOBUTYRIC ACID-postsynaptic receptor-calcium ion channel system, the receptor-mediated T-cell activation pathway, and the receptor-mediated activation of phospholipases. Those coupled to membrane depolarization or intracellular release of calcium include the receptor-mediated activation of cytotoxic functions in granulocytes and the synaptic potentiation of protein kinase activation. Some signal transduction pathways may be part of larger signal transduction pathways; for example, protein kinase activation is part of the platelet activation signal pathway. Cell Signaling,Receptor-Mediated Signal Transduction,Signal Pathways,Receptor Mediated Signal Transduction,Signal Transduction Pathways,Signal Transduction Systems,Pathway, Signal,Pathway, Signal Transduction,Pathways, Signal,Pathways, Signal Transduction,Receptor-Mediated Signal Transductions,Signal Pathway,Signal Transduction Pathway,Signal Transduction System,Signal Transduction, Receptor-Mediated,Signal Transductions,Signal Transductions, Receptor-Mediated,System, Signal Transduction,Systems, Signal Transduction,Transduction, Signal,Transductions, Signal
D015539 Platelet Activation A series of progressive, overlapping events, triggered by exposure of the PLATELETS to subendothelial tissue. These events include shape change, adhesiveness, aggregation, and release reactions. When carried through to completion, these events lead to the formation of a stable hemostatic plug. Activation, Platelet,Activations, Platelet,Platelet Activations
D015854 Up-Regulation A positive regulatory effect on physiological processes at the molecular, cellular, or systemic level. At the molecular level, the major regulatory sites include membrane receptors, genes (GENE EXPRESSION REGULATION), mRNAs (RNA, MESSENGER), and proteins. Receptor Up-Regulation,Upregulation,Up-Regulation (Physiology),Up Regulation

Related Publications

Yoshio Matsui, and Hideki Amano, and Yoshiya Ito, and Koji Eshima, and Tastunori Suzuki, and Fumihiro Ogawa, and Akira Iyoda, and Yukitoshi Satoh, and Shintaro Kato, and Masaki Nakamura, and Hidero Kitasato, and Shuh Narumiya, and Masataka Majima
August 1995, Biokhimiia (Moscow, Russia),
Yoshio Matsui, and Hideki Amano, and Yoshiya Ito, and Koji Eshima, and Tastunori Suzuki, and Fumihiro Ogawa, and Akira Iyoda, and Yukitoshi Satoh, and Shintaro Kato, and Masaki Nakamura, and Hidero Kitasato, and Shuh Narumiya, and Masataka Majima
November 2000, Blood,
Yoshio Matsui, and Hideki Amano, and Yoshiya Ito, and Koji Eshima, and Tastunori Suzuki, and Fumihiro Ogawa, and Akira Iyoda, and Yukitoshi Satoh, and Shintaro Kato, and Masaki Nakamura, and Hidero Kitasato, and Shuh Narumiya, and Masataka Majima
August 1995, Proceedings of the National Academy of Sciences of the United States of America,
Yoshio Matsui, and Hideki Amano, and Yoshiya Ito, and Koji Eshima, and Tastunori Suzuki, and Fumihiro Ogawa, and Akira Iyoda, and Yukitoshi Satoh, and Shintaro Kato, and Masaki Nakamura, and Hidero Kitasato, and Shuh Narumiya, and Masataka Majima
July 2015, Life sciences,
Yoshio Matsui, and Hideki Amano, and Yoshiya Ito, and Koji Eshima, and Tastunori Suzuki, and Fumihiro Ogawa, and Akira Iyoda, and Yukitoshi Satoh, and Shintaro Kato, and Masaki Nakamura, and Hidero Kitasato, and Shuh Narumiya, and Masataka Majima
August 2002, Cancer research,
Yoshio Matsui, and Hideki Amano, and Yoshiya Ito, and Koji Eshima, and Tastunori Suzuki, and Fumihiro Ogawa, and Akira Iyoda, and Yukitoshi Satoh, and Shintaro Kato, and Masaki Nakamura, and Hidero Kitasato, and Shuh Narumiya, and Masataka Majima
November 1999, Biochemistry. Biokhimiia,
Yoshio Matsui, and Hideki Amano, and Yoshiya Ito, and Koji Eshima, and Tastunori Suzuki, and Fumihiro Ogawa, and Akira Iyoda, and Yukitoshi Satoh, and Shintaro Kato, and Masaki Nakamura, and Hidero Kitasato, and Shuh Narumiya, and Masataka Majima
October 2007, Thrombosis and haemostasis,
Yoshio Matsui, and Hideki Amano, and Yoshiya Ito, and Koji Eshima, and Tastunori Suzuki, and Fumihiro Ogawa, and Akira Iyoda, and Yukitoshi Satoh, and Shintaro Kato, and Masaki Nakamura, and Hidero Kitasato, and Shuh Narumiya, and Masataka Majima
January 2001, Anesthesiology,
Yoshio Matsui, and Hideki Amano, and Yoshiya Ito, and Koji Eshima, and Tastunori Suzuki, and Fumihiro Ogawa, and Akira Iyoda, and Yukitoshi Satoh, and Shintaro Kato, and Masaki Nakamura, and Hidero Kitasato, and Shuh Narumiya, and Masataka Majima
February 2008, Journal of leukocyte biology,
Yoshio Matsui, and Hideki Amano, and Yoshiya Ito, and Koji Eshima, and Tastunori Suzuki, and Fumihiro Ogawa, and Akira Iyoda, and Yukitoshi Satoh, and Shintaro Kato, and Masaki Nakamura, and Hidero Kitasato, and Shuh Narumiya, and Masataka Majima
March 2000, Life sciences,
Copied contents to your clipboard!